The global Chuan Bei Qing Fei Tang Jiang market size is predicted to grow from US$ 51.3 million in 2025 to US$ 67.9 million in 2031; it is expected to grow at a CAGR of 4.8% from 2025 to 2031.

Chuan Bei Qing Fei Tang Jiang is a traditional Chinese medicine preparation, the main ingredients of which include Fritillaria cirrhosa, loquat leaves, platycodon grandiflorum and other Chinese medicinal materials with the effects of moistening the lungs, relieving cough, resolving phlegm and relieving asthma. It is widely used to treat cough, sore throat, phlegm and other symptoms caused by wind-heat or dryness, especially for dry cough without phlegm or sticky phlegm that is difficult to cough up. The syrup has a good taste and is easy to take. It is suitable for people of all ages and is one of the commonly used Chinese patent medicines for relieving respiratory discomfort and promoting recovery.

United States market for Chuan Bei Qing Fei Tang Jiang is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Chuan Bei Qing Fei Tang Jiang is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Chuan Bei Qing Fei Tang Jiang is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Chuan Bei Qing Fei Tang Jiang players cover Hubei Yujindan Pharmaceutical Co., Ltd., Hubei Yanhuang Bencao Pharmaceutical Co., Ltd., Guangxi Gehongtang Pharmaceutical Co., Ltd., Jianmin Pharmaceutical Group Co., Ltd., Jiangxi Chengzhi Yongfeng Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

Infinity Market Research newest research report, the ?Chuan Bei Qing Fei Tang Jiang Industry Forecast? looks at past sales and reviews total world Chuan Bei Qing Fei Tang Jiang sales in 2024, providing a comprehensive analysis by region and market sector of projected Chuan Bei Qing Fei Tang Jiang sales for 2025 through 2031. With Chuan Bei Qing Fei Tang Jiang sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chuan Bei Qing Fei Tang Jiang industry.

This Insight Report provides a comprehensive analysis of the global Chuan Bei Qing Fei Tang Jiang landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chuan Bei Qing Fei Tang Jiang portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Chuan Bei Qing Fei Tang Jiang market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chuan Bei Qing Fei Tang Jiang and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chuan Bei Qing Fei Tang Jiang.

This report presents a comprehensive overview, market shares, and growth opportunities of Chuan Bei Qing Fei Tang Jiang market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    100ml Per Bottle
    120ml Per Bottle

Segmentation by Application:

    Hospital
    Clinic
    Other

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Hubei Yujindan Pharmaceutical Co., Ltd.
    Hubei Yanhuang Bencao Pharmaceutical Co., Ltd.
    Guangxi Gehongtang Pharmaceutical Co., Ltd.
    Jianmin Pharmaceutical Group Co., Ltd.
    Jiangxi Chengzhi Yongfeng Pharmaceutical Co., Ltd.
    Hubei Meisichuang Pharmaceutical Co., Ltd.
    Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd.
    Hubei Wushi Pharmaceutical Co., Ltd.
    Huiyingbi Group Anhui Pharmaceutical Co., Ltd.
    Sunflower Pharmaceutical Group Hubei Wudang Co., Ltd.
    Hubei Nordeson Pharmaceutical Co., Ltd.
    Wuhan Jianmin Dapeng Pharmaceutical Co., Ltd.
    Guangxi Zhengtang Pharmaceutical Co., Ltd.
    Guangdong Yihe Pharmaceutical Co., Ltd.
    Guangxi Shibiao Pharmaceutical Co., Ltd.
    Guangxi Tiantianle Pharmaceutical Co., Ltd.
    Guangxi Hercules Pharmaceutical Co., Ltd.
    Shanghai Baolong Anqing Pharmaceutical Co., Ltd.
    Wuhan Kangle Pharmaceutical Co., Ltd.
    Jiangxi Puzheng Pharmaceutical Co., Ltd.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Chuan Bei Qing Fei Tang Jiang market?
What factors are driving Chuan Bei Qing Fei Tang Jiang market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Chuan Bei Qing Fei Tang Jiang market opportunities vary by end market size?
How does Chuan Bei Qing Fei Tang Jiang break out by Type, by Application?